Article Sidebar

Submitted
Apr 21, 2021
Published
Apr 21, 2021
Download
PDF
Statistic
Read Counter : 61 Download : 26

Main Article Content

Abstract

Introduction


Neurological disorders have been estimated to account for up to 20% of the nationwide cost of healthcare in developed countries. There is growing concern to assess the Adverse Drug Reactions (ADRs) of anti-epileptic drugs (AEDs), which have an impact on compliance, economic burden and quality of life. AEDs have broad spectrum of effects, need long term therapy leading to wide range of ADRs. Thus, the present study was undertaken.


Aim


To assess the incidence, severity, causality of ADRs due to AEDs and to compare the pattern of ADRs caused by conventional versus newer AEDs.


Methodology


This observational study was carried out from 2012 to 2016 to analyze the ADRs reported spontaneously from Department of Neurology at Bangalore Medical College and Research Institute to ADR monitoring centre. Patient demographics, clinical & drug data, details of ADR, onset time, causal drug details, outcome and severity were collected as per CDSCO ADR reporting form. Causality was assessed using WHO-ADR probability scale, preventability by Modified Schumock& Thornton scale and severity using Hartwig and Siegel Scale. Predictability was categorized as Type A and Type B ADRs.


Results


85 ADRs were reported in 5 years, with maximum in 21-40 yrs and equal male to female ratio. Conventional AEDs (75%), mainly Phenytoin (40%) and Carbamazepine (27%) contributed the most. Amongst newer AEDs, Levetiractam accounted for maximum ADRs (13%) followed by Gabapentin (10%). ADRs affecting Central Nervous System (CNS) (65%) were predominant in both groups. Newer AEDs caused Giddiness 10.7 times more frequently than conventional ones. Erythematous rash was 1.71 times more in the conventional drugs than newer ones. Frequency of drug withdrawal was higher among the patients on conventional AEDs (60% vs 30%). Causality assessment indicated that 90% had probable and 10% had possible causality. Majority of the ADRs in both the groups were of moderate severity (50%). The severe ADRs (7%) seen only with conventional AEDs were hepatotoxicity & pancreatitis due to Sodium Valproate and hyponatraemia due to Carbamazepine. Definitely preventable ADRs (12%) were noted among both the groups. No mortality was reported.


Conclusion

85 ADRs due to AEDs were reported in 5 years period. Among conventional AEDs, Phenytoin and Carbamazepine contributed the maximum. Amongst newer AEDs, Levetiractam, followed by Gabapentin were implicated in majority of ADRs. ADRs affecting CNS were predominant in both groups. Severe ADRs were seen with only conventional AEDs.

Keywords

Anti-epileptic drugs Adverse drug reactions Causality assessment scale Severity

Article Details

How to Cite
C. R. Jayanthi, & Arjun Subash. (2021). Comparing the adverse drug reactions of conventional versus newer anti epileptic drugs: an observational study. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(2), 247-254. https://doi.org/10.61096/ijrpp.v6.iss2.2017.247-254
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Srinivasan R, Ramya G. Adverse drug reactions- causality assessment. Int J Res Pharm Chemist. 1(3), 2011, 606-612.
  2. [2]. Raut AL, Patel P, Patel C, Pawar A. Preventability, Predictability and Seriousness of Adverse Drug Reactions amongst Medicine Inpatients in a Teaching Hospital: A Prospective Observational Study. International Journal of Pharmaceutical and Chemical Sciences. 1 (3), 2012, 1293- 1299.
  3. [3]. Santosh NS, Sinha S, Satishchandra P. Epilepsy: Indian perspective. Ann Indian Acad Neurol. 17(1), 2014, S3- S11
  4. [4]. Thomas SV, Nair A. Confronting the stigma of epilepsy. Ann Indian Acad Neurol. 14(3), 2011, 158- 163
  5. [5]. Chung SS. New treatment option for partial-onset seizures: efficacy and safety of lacosamide. TherAdvNeurolDisord. 3(2), 2010, 77–83.
  6. [6]. Gajjar BM, Shah AM, Patel PM. The pattern of adverse drug events to antiepileptic drugs: A cross-sectional study at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol 6(1), 2016, Doi: 10.5455/ njppp.2016.6.0823013082016.
  7. [7]. Mathur S, Sen S, Ramesh L, Kumar S. Utilization pattern of antiepileptic drugs and their adverse effects, in a teaching hospital. Asian Journal of Pharmaceutical and Clinical Research. 3(1), 2010, 55
  8. [8]. Jayanthi CR, Divyashree M, Sushma M. Adverse drug reactions in psychiatry outpatients: Clinical spectrum, causality and avoidability. Journal of Chemical and Pharmaceutical Research. 5(8), 2013, 128-135.
  9. [9]. Mukherjee S, Sen S, Chatterjee SS, Era N, Ghosal M, Tripathi SK. Adverse drug reaction monitoring of antidepressants in the psychiatry out- patient department at a tertiary care teaching hospital in India: A cross-sectional observational study. Eur J PsycholEduc Studies 2, 2015, 14-9.
  10. [10]. Moulya MV, Dinesh R, Nagesh G. Pattern of adverse drug reaction in teaching care hospital in southern India: a retrospective study. 5(6), 2015, 1429-1439.
  11. [11]. French JA, Gazzola DM. New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety? TherAdv Drug Saf. 2(4), 2011, 141158
  12. [12]. Perucca P, Jacoby A, Marson AG, Baker GA, Lane S, Benn EK, et al. Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology. 76(3), 2011, 273-9.
  13. [13]. Pal A, Prusty SK, Sahu PK, Swain T. Drug utilization pattern of antiepileptic drugs: A pharmacoepidemiologic and pharmacovigilance study in a tertiary teaching hospital in India. Asian J Pharm Clin Res. 4(1), 2011, 96-9.
  14. [14]. Perucca E, Berlowitz D, Birnbaum A, Cloyd JC, Garrard J, Hanlon JT et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Research. 2005, 1-15.
  15. [15]. Perucca E. Adverse effects of antiepileptic drugs. Focus Farmacovigilanza. 80(1), 2014, 1
  16. [16]. Eddy CM, Rickards HE, Cavanna AE. The cognitive impact of antiepileptic drugs. TherAdvNeurolDisord. 4(6), 2011, 385–407.
  17. [17]. Keerthy J, Kavitha P, Sambathkumar R, Sruthi A. A Study on the Adverse Drug Reactions Induced by Anti Epileptic Drugs in the Epileptic Patients. J App Pharm Sci, 6(5), 2016, 119-123.
  18. [18]. Ghaffarpour M, Hejazie SS, Harirchian MH, Pourmahmoodian H. Phenytion, carbamazepine, sodium valproate and lamotrigine induced cutaneous reactions. Acta Med Iran, 43(1), 2005, 37-42.
  19. [19]. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 5(1), 2010, 39.
  20. [20]. Silva MFB, Aires CCP, Luis PBM, Ruites JPN, Ijlst L, Duran M et al. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis. 31, 2008, 205- 216
  21. [21]. Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA. Long-term anticonvulsant therapy leads to low bone mineral density-evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. ExpClinEndocrinol Diabetes. 108(1), 2000, 37-43.
  22. [22]. Valsamis HA, Arora SK, Labban B, McFarlane SI. Antiepileptic drugs and bone metabolism. Nutrition & Metabolism.3, 2006, 1-11
  23. [23]. Vestergaard P, Rejnmark L, Mosekilde L: Fracture risk associated with use of antiepileptic drugs. Epilepsia45, 2004, 1330-1337.
  24. [24]. Pack AM, Gidal B, Vazquez B: Bone disease associated with antiepileptic drugs. Cleve Clin J Med71(2), 2004, S42-8.